Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Circulation|October 15, 1996
The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin StudyJ W Jukema, A J van Boven, B Groenemeijer, et al.
Circulation|November 14, 1997
Thermolabile methylenetetrahydrofolate reductase in coronary artery diseaseL A Kluijtmans, J J Kastelein, J Lindemans, et al.
Circulation|March 10, 2001
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery diseaseS M Clee, A H Zwinderman, J C Engert, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 10, 2012
Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formationMaryline Olivier, Michael W Tanck, Ruud Out, et al.
Clinical Cardiology|February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study GroupL Ose, M H Davidson, E A Stein, et al.
Journal of Lipid Research|June 4, 2014
Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humansRoshni R Singaraja, Ian Tietjen, G Kees Hovingh, et al.
The Journal of Clinical Investigation|November 22, 2000
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase geneE Ehrenborg, S M Clee, S N Pimstone, et al.
Lancet (London, England)|October 26, 1999
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol effluxM Marcil, A Brooks-Wilson, S M Clee, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2026
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisationAsahi Oshima, Patrick W Serruys, Scot Garg, et al.
Pageof 19